Clinical Trials Logo

Clinical Trial Summary

This is an initial evaluation of the 480 Biomedical Bioresorbable Scaffold System for the treatment of subjects with de novo native superficial femoral artery lesions.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Atherosclerosis
  • Atherosclerosis of Femoral Artery
  • Superficial Femoral Artery Lesions

NCT number NCT01403077
Study type Interventional
Source Lyra Therapeutics
Contact
Status Completed
Phase N/A
Start date October 2011
Completion date October 2015

See also
  Status Clinical Trial Phase
Completed NCT03271710 - Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System N/A
Completed NCT01327950 - Efficacy of the EPIC Nitinol Vascular Stent System in Superficial Femoral Artery (SFA) Lesions N/A
Completed NCT01700075 - Physical and Chemical Study of Atherosclerosis Mechanisms Phase 4
Active, not recruiting NCT04597307 - IN.PACTâ„¢ Quality of Life Post-Reimbursement Study
Recruiting NCT03751527 - ZENFlex-Registry to Evaluate the Outcome of Bare Metal Stent-assisted Angioplasty N/A
Recruiting NCT06416644 - The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry) N/A